CIBC Bancorp USA’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.94M Sell
64,067
-20,306
-24% -$1.48M 0.01% 757
2026
Q1
$5.51M Buy
+84,373
New +$6.27M 0.01% 677
2025
Q3
$1.51M Buy
+20,631
New +$1.51M 0.01% 632

Other funds holding SOLV

CIBC Bancorp USA's SOLV Position: Q2 2026 in Review

CIBC Bancorp USA reduced its Solventum (SOLV) stake by 24% in Q2 2026, selling an estimated $1.48M and leaving 64,067 shares worth $4.94M. The position accounts for 0.01% of the portfolio, ranked #757.

CIBC Bancorp USA first reported a position in SOLV in Q3 2025 and has held it in 3 quarters since. The position peaked at $5.51M in Q1 2026. 835 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

  • CIBC Bancorp USA held 64,067 shares of Solventum worth $4.94M as of Q2 2026.
  • CIBC Bancorp USA sold 20,306 Solventum shares in Q2 2026, an estimated $1.48M.
  • Solventum made up 0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #757 holding.
  • CIBC Bancorp USA first reported a position in Solventum in Q3 2025 and has held it in 3 quarters since.
  • CIBC Bancorp USA's Solventum position peaked at $5.51M in Q1 2026.
  • 835 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.